Epidermal growth factor receptor (EGFR) expression in operable non-small cell lung carcinoma

scientific article

Epidermal growth factor receptor (EGFR) expression in operable non-small cell lung carcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3346/JKMS.2004.19.4.529
P932PMC publication ID2816886
P698PubMed publication ID15308843
P5875ResearchGate publication ID8402164

P50authorCheolwon SuhQ92139867
P2093author name stringSeung-Mo Hong
Jung-Shin Lee
Sang-We Kim
Woo Kun Kim
Jin-Hee Ahn
In Chul Lee
P2860cites workEpidermal Growth FactorQ34192014
EGFR and cancer prognosisQ34399312
Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.Q34536780
Biological role of epidermal growth factor-receptor clustering. Investigation with monoclonal anti-receptor antibodiesQ34708312
Epidermal growth factor receptors and cyclooxygenase-2 in the pathogenesis of non-small cell lung cancer: potential targets for chemoprevention and systemic therapyQ35033434
The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survivalQ35976186
Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroupQ35982514
Epidermal growth factor receptors in non-small cell lung cancerQ36028055
Enzyme-linked immunosorbent assay of epidermal growth factor receptor in lung cancer: comparisons with immunohistochemistry, clinicopathological features and prognosis.Q36114819
Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosectionsQ36135626
Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma.Q36138893
Epidermal growth factor receptor status of histological sub-types of breast cancerQ36466662
Human squamous cell lung cancers express increased epidermal growth factor receptorsQ36993618
Molecular and pathologic markers in stage I non-small-cell carcinoma of the lungQ40518313
Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development.Q40607681
Epidermal growth factor receptor in lung malignancies. Comparison between cancer and normal tissueQ42372154
Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomasQ43687666
Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer.Q43927698
Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor).Q44588191
Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancerQ44750877
Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lungQ45037436
A comparison of epidermal growth factor receptor levels and other prognostic parameters in non-small cell lung cancer.Q50976951
Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences.Q53554133
Postoperative adjuvant chemotherapy and radiotherapy for stage II and III non-small cell lung cancer (NSCLC).Q53669174
Study of prognostic predictors for non-small cell lung cancer.Q53759964
Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancerQ58212506
Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtypeQ59219690
EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patientsQ61853733
Prognostic and predictive value of intratumoral microvessels density in operable non-small-cell lung cancerQ63342942
Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progressionQ63548690
Expression of epidermal growth factor receptor in human gastric and colonic carcinomasQ69012326
Characterization and quantitation of the epidermal growth factor receptor in invasive and superficial bladder tumorsQ69746810
Long-term outcome related to epidermal growth factor receptor status in bladder cancerQ72539394
Value of Ki-67 immunostaining in preoperative biopsies of carcinomas of the lungQ73046039
Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancersQ73122506
Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancerQ79370322
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P433issue4
P304page(s)529-535
P577publication date2004-08-01
P1433published inJournal of Korean Medical ScienceQ24039955
P1476titleEpidermal growth factor receptor (EGFR) expression in operable non-small cell lung carcinoma
P478volume19

Reverse relations

cites work (P2860)
Q58787276Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients
Q36439246Correlation study and significance of the EGFR expression in serum, lymph nodes and tumor tissue of NSCLC
Q36216537Erlotinib treatment in pretreated patients with non-small cell lung cancer: A Phase II study
Q36010179Expression of EGFR Is Closely Related to Reduced 3-Year Survival Rate in Chinese Female NSCLC
Q46114914The immunohistochemical expression of cyclooxygenase 2 is inversely associated with (18)F-FDG-PET SUV values in non-small-cell lung cancers. Initial results